Interestingly, CKD patients recruited into this study with diabetes mellitus (DM) (1253±170.1 pg/ml, n = 68) had significantly higher plasma FGF21 levels (P = 0.0016) than those without DM (714±82.1 pg/ml, n = 132). This evidence concerns the gene FGF21 and chronic kidney disease.